TY - JOUR
T1 - Acute kidney injury is an unfavorable prognostic factor in acute liver failure and is associated with tumor necrosis factor-alpha
AU - Imoto, Koji
AU - Tanaka, Masatake
AU - Goya, Takeshi
AU - Azuma, Yuki
AU - Hioki, Tomonobu
AU - Aoyagi, Tomomi
AU - Takahashi, Motoi
AU - Kurokawa, Miho
AU - Kato, Masaki
AU - Kohjima, Motoyuki
AU - Ogawa, Yoshihiro
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/11/10
Y1 - 2023/11/10
N2 - Acute kidney injury (AKI) is a common complication of acute liver failure (ALF); but its pathogenesis is unknown. ALF was divided into 2 subgroups; ALF with hepatic coma, which corresponds to ALF in the US and Europe, and ALF without hepatic coma. AKI has been shown to worsen the prognosis of ALF patients with hepatic coma; however, its prognostic significance in ALF without hepatic coma remains unknown. A single-center retrospective study of 174 patients with ALF was performed. AKI was defined according to KDIGO criteria. AKI developed in 29 (66.0%) of 44 ALF patients with hepatic coma and 27 (38.5%) of 130 ALF patients without hepatic coma. Systemic inflammatory response syndrome (SIRS) was found to be significantly associated with AKI incidence in ALF patients (P <.001). Tumor necrosis factor-alpha (TNF-α) was found to be significantly associated with the presence and severity of AKI (P =.0039 and P =.0140, respectively). On multivariate analysis, TNF-α was an independent risk factor linked with AKI (P =.0103). Even in the absence of hepatic coma, the transplant-free survival rate of ALF was significantly associated with the presence and severity of AKI. Even when hepatic coma is absent, AKI complicated in ALF is strongly associated with TNF-α and worsens the transplant-free survival rate. Before the onset of hepatic coma, plasma exchange, or extracorporeal blood purification to remove inflammatory cytokines should be considered in ALF patients.
AB - Acute kidney injury (AKI) is a common complication of acute liver failure (ALF); but its pathogenesis is unknown. ALF was divided into 2 subgroups; ALF with hepatic coma, which corresponds to ALF in the US and Europe, and ALF without hepatic coma. AKI has been shown to worsen the prognosis of ALF patients with hepatic coma; however, its prognostic significance in ALF without hepatic coma remains unknown. A single-center retrospective study of 174 patients with ALF was performed. AKI was defined according to KDIGO criteria. AKI developed in 29 (66.0%) of 44 ALF patients with hepatic coma and 27 (38.5%) of 130 ALF patients without hepatic coma. Systemic inflammatory response syndrome (SIRS) was found to be significantly associated with AKI incidence in ALF patients (P <.001). Tumor necrosis factor-alpha (TNF-α) was found to be significantly associated with the presence and severity of AKI (P =.0039 and P =.0140, respectively). On multivariate analysis, TNF-α was an independent risk factor linked with AKI (P =.0103). Even in the absence of hepatic coma, the transplant-free survival rate of ALF was significantly associated with the presence and severity of AKI. Even when hepatic coma is absent, AKI complicated in ALF is strongly associated with TNF-α and worsens the transplant-free survival rate. Before the onset of hepatic coma, plasma exchange, or extracorporeal blood purification to remove inflammatory cytokines should be considered in ALF patients.
UR - http://www.scopus.com/inward/record.url?scp=85176900178&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85176900178&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000035931
DO - 10.1097/MD.0000000000035931
M3 - Article
C2 - 37960809
AN - SCOPUS:85176900178
SN - 0025-7974
VL - 102
SP - E35931
JO - Medicine (United States)
JF - Medicine (United States)
IS - 45
ER -